Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Phase II Study of Loncastuximab Tesirine as Consolidation Strategy in Patients With LBCL in PR After CAR T-cell Therapy
Apply
Loncastuximab Tesirine
A Phase II Study of Loncastuximab Tesirine as Consolidation Strategy in Patients With LBCL in PR After CAR T-cell Therapy
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step